What's Happening With BioNTech SE Shares?

Shares of vaccine companies, including BioNTech SE - ADR BNTX, are trading higher amid COVID-19 concerns due to rising cases in China.

Rising COVID-19 cases in China's capital Beijing and Shanghai, where enforcement of a strict "zero-COVID" policy is ongoing, have drawn global attention. 

The world's second-largest economy has been struggling to completely stamp out the pandemic as traders and investors weigh increasing infections in the region.

See Also: Why Axsome Therapeutics Stock Is Falling Today

BioNTech SE develops cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19.

According to data from Benzinga Pro, BioNTech has a 52-week high of $464.00 and a 52-week low of $121.32.